X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs ALKEM LABORATORIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE ALKEM LABORATORIES TTK HEALTHCARE/
ALKEM LABORATORIES
 
P/E (TTM) x 17.5 - - View Chart
P/BV x 4.5 6.3 71.4% View Chart
Dividend Yield % 0.6 0.7 94.0%  

Financials

 TTK HEALTHCARE   ALKEM LABORATORIES
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
ALKEM LABORATORIES
Mar-16
TTK HEALTHCARE/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs6631,589 41.7%   
Low Rs3991,232 32.4%   
Sales per share (Unadj.) Rs535.6417.5 128.3%  
Earnings per share (Unadj.) Rs15.956.3 28.3%  
Cash flow per share (Unadj.) Rs20.064.7 30.9%  
Dividends per share (Unadj.) Rs4.0012.70 31.5%  
Dividend yield (eoy) %0.80.9 83.6%  
Book value per share (Unadj.) Rs137.6292.9 47.0%  
Shares outstanding (eoy) m7.77119.57 6.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.4 29.4%   
Avg P/E ratio x33.325.1 133.0%  
P/CF ratio (eoy) x26.521.8 121.7%  
Price / Book Value ratio x3.94.8 80.2%  
Dividend payout %25.122.6 111.2%   
Avg Mkt Cap Rs m4,127168,653 2.4%   
No. of employees `0001.7NA-   
Total wages/salary Rs m6079,171 6.6%   
Avg. sales/employee Rs Th2,436.7NM-  
Avg. wages/employee Rs Th355.2NM-  
Avg. net profit/employee Rs Th72.5NM-  
INCOME DATA
Net Sales Rs m4,16249,915 8.3%  
Other income Rs m611,645 3.7%   
Total revenues Rs m4,22351,561 8.2%   
Gross profit Rs m1978,482 2.3%  
Depreciation Rs m321,006 3.2%   
Interest Rs m30671 4.5%   
Profit before tax Rs m1978,451 2.3%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m731,606 4.5%   
Profit after tax Rs m1246,731 1.8%  
Gross profit margin %4.717.0 27.9%  
Effective tax rate %37.019.0 194.8%   
Net profit margin %3.013.5 22.1%  
BALANCE SHEET DATA
Current assets Rs m1,62927,062 6.0%   
Current liabilities Rs m1,05815,324 6.9%   
Net working cap to sales %13.723.5 58.3%  
Current ratio x1.51.8 87.2%  
Inventory Days Days3067 44.8%  
Debtors Days Days3441 81.4%  
Net fixed assets Rs m55612,610 4.4%   
Share capital Rs m78239 32.5%   
"Free" reserves Rs m87834,490 2.5%   
Net worth Rs m1,06935,027 3.1%   
Long term debt Rs m1591,212 13.1%   
Total assets Rs m2,39954,387 4.4%  
Interest coverage x7.613.6 55.7%   
Debt to equity ratio x0.10 429.1%  
Sales to assets ratio x1.70.9 189.0%   
Return on assets %6.413.6 47.1%  
Return on equity %11.619.2 60.3%  
Return on capital %18.524.9 74.2%  
Exports to sales %0.812.9 6.1%   
Imports to sales %1.43.1 45.4%   
Exports (fob) Rs m336,461 0.5%   
Imports (cif) Rs m581,540 3.8%   
Fx inflow Rs m336,563 0.5%   
Fx outflow Rs m633,012 2.1%   
Net fx Rs m-303,552 -0.9%   
CASH FLOW
From Operations Rs m1277,259 1.7%  
From Investments Rs m-1461,864 -7.8%  
From Financial Activity Rs m22-9,273 -0.2%  
Net Cashflow Rs m3-150 -1.7%  

Share Holding

Indian Promoters % 65.4 66.9 97.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 33.1 11.2%  
FIIs % 5.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 0.0 -  
Shareholders   12,723 68,381 18.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   TORRENT PHARMA  NATCO PHARMA  AJANTA PHARMA  SANOFI INDIA  DR. DATSONS LABS  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

US-China Trade Talks, Oil Prices, and Top Stocks in Action Today(Pre-Open)

On Tuesday, share markets in India witnessed selling pressure during closing hours and ended their trading session marginally lower after a volatile day of trading.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 43.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, TTK HEALTHCARE has posted a net profit of Rs 80 m (up 43.1% YoY). Sales on the other hand came in at Rs 1 bn (up 21.4% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 19, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS